Xiaoyan Lin

机构：Shandong Provincial Hospital, Shandong First Medical University · ORCID：0000-0003-3515-3819

发表论文 148 篇 · 总被引 6582 次 · h-index 25

代表论文

• Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial (2025 · The Lancet · 被引 128)
• Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study (2024 · Journal for ImmunoTherapy of Cancer · 被引 26)
• Simple Sitting Baduanjin mind-body exercise: randomized controlled trial protocol for advanced cancer patients with the fatigue-sleep disturbance symptom cluster (2024 · BMC Complementary Medicine and Therapies · 被引 13)
• Comparison of Remimazolam-Flumazenil and Propofol on Psychomotor Function and Emergence Following General Anesthesia in Surgical Abortion: A Randomized Controlled Trial (2024 · Drug Design Development and Therapy · 被引 11)
• Participation in medication safety of older-adult patients with chronic disease during the transition from hospital to home: a descriptive qualitative study (2024 · BMC Geriatrics · 被引 6)
• Involvement in medication safety behaviors among older people with chronic diseases: systematic review of intervention studies (2024 · BMC Geriatrics · 被引 5)